In addition, human adipose-derived MSC-based therapy alleviated serum leptin levels and/or the leptin-adiponectin ratio, which is an important index for predicting the risk of obesity-related disorders96,97. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.